Implication of linker length on cell cytotoxicity, pharmacokinetic and toxicity profile of gemcitabine-docetaxel combinatorial dual drug conjugate

Show simple item record

dc.contributor.author Kushwah, V.
dc.contributor.author Katiyar, S.S.
dc.contributor.author Agrawal, A.K.
dc.contributor.author Saraf, I.
dc.contributor.author Singh, I.P.
dc.contributor.author Lamprou, D.A.
dc.contributor.author Gupta, R.C.
dc.date.accessioned 2021-02-10T06:47:50Z
dc.date.available 2021-02-10T06:47:50Z
dc.date.issued 2018-09-05
dc.identifier.issn 03785173
dc.identifier.uri http://localhost:8080/xmlui/handle/123456789/1299
dc.description.abstract The present study investigates effect of linkers [zero length (without linker), short length linker (glycine and lysine) and long length linker (PEG1000, PEG2000 and PEG3500)] on pharmacokinetics and toxicity of docetaxel (DTX) and gemcitabine (GEM) bio-conjugates. Conjugates were synthesized via carbodiimide chemistry and characterized by 1H NMR and FTIR. Conjugation of DTX and GEM via linkers showed diverse physiochemical and plasma stability profile. Cellular uptake mechanism in MCF-7 and MDA-MB-231 cell lines revealed clathrin mediated internalization of bio-conjugates developed by using long length linkers, leading to higher cytotoxicity compared with free drug congeners. DTX-PEG3500-GEM and DTX-PEG2000-GEM demonstrated 4.21 and 3.81-fold higher AUC(0-∞) of GEM in comparison with GEM alone. DTX-PEG2000-GEM and DTX-PEG3500-GEM exhibited reduced hepato-, nephro- and haemolytic toxicity as evident via histopathology, biochemical markers and SEM analysis of RBCs. Conclusively, PEG2000 and PEG3500 significantly improved pharmacokinetics without any sign of toxicity and hence can be explored further for the development of dual-drug conjugates for better therapeutic efficacy. © 2018 Elsevier B.V. en_US
dc.description.sponsorship Bangladesh Council of Scientific and Industrial Research Council of Scientific and Industrial Research (CSIR) en_US
dc.language.iso en_US en_US
dc.publisher Elsevier B.V. en_US
dc.relation.ispartofseries International Journal of Pharmaceutics;Vol. 548, Issue 1
dc.subject Docetaxel en_US
dc.subject Gemcitabine en_US
dc.subject Dual drug delivery en_US
dc.subject Bio-conjugation en_US
dc.subject Linker screening en_US
dc.subject Prodrug en_US
dc.title Implication of linker length on cell cytotoxicity, pharmacokinetic and toxicity profile of gemcitabine-docetaxel combinatorial dual drug conjugate en_US
dc.type Article en_US


Files in this item

This item appears in the following Collection(s)

Show simple item record

Search in IDR


Advanced Search

Browse

My Account